BlackRock’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,280,968
| Closed | -$319M | – | 5050 |
|
|
2018
Q4 | $319M | Buy |
2,280,968
+9,540
| +0.4% | +$1.34M | 0.02% | 949 |
|
|
2018
Q3 | $388M | Buy |
2,271,428
+176,264
| +8% | +$30.1M | 0.02% | 945 |
|
|
2018
Q2 | $363M | Buy |
2,095,164
+280,475
| +15% | +$48.7M | 0.02% | 972 |
|
|
2018
Q1 | $209M | Sell |
1,814,689
-26,647
| -1% | -$3.07M | 0.01% | 1322 |
|
|
2017
Q4 | $155M | Sell |
1,841,336
-10,755
| -0.6% | -$905K | 0.01% | 1561 |
|
|
2017
Q3 | $171M | Buy |
1,852,091
+249,206
| +16% | +$23M | 0.01% | 1480 |
|
|
2017
Q2 | $129M | Buy |
1,602,885
+273,291
| +21% | +$21.9M | 0.01% | 1618 |
|
|
2017
Q1 | $55.9M | Buy |
1,329,594
+1,328,061
| +86,632% | +$55.9M | ﹤0.01% | 2136 |
|
|
2016
Q4 | $49K | Sell |
1,533
-33
| -2% | -$1.06K | ﹤0.01% | 2887 |
|
|
2016
Q3 | $41K | Buy |
1,566
+851
| +119% | +$22.3K | ﹤0.01% | 3005 |
|
|
2016
Q2 | $17K | Buy |
715
+394
| +123% | +$9.37K | ﹤0.01% | 3274 |
|
|
2016
Q1 | $9K | Buy |
+321
| New | +$9K | ﹤0.01% | 3167 |
|